Trial intelligence / Profile preview

Mobile Health for Tobacco Cessation in Laos

NCT05233228Phase 2Recruiting

Sponsor
University of Oklahoma
Start
Apr 2022
Primary completion
Aug 2026
Countries
1
01

Overview

Phase 2, randomised, open-label trial (2 arms), sponsored by University of Oklahoma. Primary endpoints: Biochemically confirmed self-reported 7-day point prevalence abstinence at 12 months and Smoking status at 3 months post-enrollment. Started Apr 2022; status: recruiting.

Beyond the preview

Go deeper on NCT05233228.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05233228.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call